Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial
- PMID: 33855215
- PMCID: PMC8029500
- DOI: 10.1002/edm2.213
Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial
Abstract
Aims: Lipid metabolism might be compromised in type 1 diabetes, and the understanding of lipid physiology is critically important. This study aimed to compare the change in plasma lipid concentrations during carbohydrate dietary changes in individuals with type 1 diabetes and identify links to early-stage dyslipidaemia. We hypothesized that (1) the lipidomic profiles after ingesting low or high carbohydrate diet for 12 weeks would be different; and (2) specific annotated lipid species could have significant associations with metabolic outcomes.
Methods: Ten adults with type 1 diabetes (mean ± SD: age 43.6 ± 13.8 years, diabetes duration 24.5 ± 13.4 years, BMI 24.9 ± 2.1 kg/m2, HbA1c 57.6 ± 2.6 mmol/mol) using insulin pumps participated in a randomized 2-period crossover study with a 12-week intervention period of low carbohydrate diet (< 100 g carbohydrates/day) or high carbohydrate diet (> 250 g carbohydrates/day), respectively, separated by a 12-week washout period. A large-scale non-targeted lipidomics was performed with mass spectrometry in fasting plasma samples obtained before and after each diet intervention. Longitudinal lipid levels were analysed using linear mixed-effects models.
Results: In total, 289 lipid species were identified from 14 major lipid classes. Comparing the two diets, 11 lipid species belonging to sphingomyelins, phosphatidylcholines and LPC(O-16:0) were changed. All the 11 lipid species were significantly elevated during low carbohydrate diet. Two lipid species were most differentiated between diets, namely SM(d36:1) (β ± SE: 1.44 ± 0.28, FDR = 0.010) and PC(P-36:4)/PC(O-36:5) (β ± SE: 1.34 ± 0.25, FDR = 0.009) species. Polyunsaturated PC(35:4) was inversely associated with BMI and positively associated with HDL cholesterol (p < .001).
Conclusion: Lipidome-wide outcome analysis of a randomized crossover trial of individuals with type 1 diabetes following a low carbohydrate diet showed an increase in sphingomyelins and phosphatidylcholines which are thought to reduce dyslipidaemia. The polyunsaturated phosphatidylcholine 35:4 was inversely associated with BMI and positively associated with HDL cholesterol (p < .001). Results from this study warrant for more investigation on the long-term effect of single lipid species in type 1 diabetes.
Trial registration: ClinicalTrials.gov NCT02888691.
Keywords: cardiovascular disease; dyslipidaemia; lipidomics; low carbohydrate diet; randomized trial; type 1 diabetes.
© 2021 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.
Conflict of interest statement
None of the investigators has personal interests in the conduct or the outcomes of the study.
Figures

Similar articles
-
Moderate replacement of carbohydrates by dietary fats affects features of metabolic syndrome: a randomized crossover clinical trial.Nutrition. 2014 Jan;30(1):61-8. doi: 10.1016/j.nut.2013.06.011. Nutrition. 2014. PMID: 24290600 Clinical Trial.
-
Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial.Am J Clin Nutr. 2015 Oct;102(4):780-90. doi: 10.3945/ajcn.115.112581. Epub 2015 Jul 29. Am J Clin Nutr. 2015. PMID: 26224300 Clinical Trial.
-
A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial.Diabetologia. 2019 Nov;62(11):2066-2078. doi: 10.1007/s00125-019-4956-4. Epub 2019 Jul 23. Diabetologia. 2019. PMID: 31338545 Clinical Trial.
-
Carbohydrate quantity in the dietary management of type 2 diabetes: A systematic review and meta-analysis.Diabetes Obes Metab. 2019 Jan;21(1):15-27. doi: 10.1111/dom.13499. Epub 2018 Sep 10. Diabetes Obes Metab. 2019. PMID: 30098129
-
Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis.Nutr Rev. 2019 Mar 1;77(3):161-180. doi: 10.1093/nutrit/nuy049. Nutr Rev. 2019. PMID: 30544168
Cited by
-
Machine learning approach reveals microbiome, metabolome, and lipidome profiles in type 1 diabetes.J Adv Res. 2024 Oct;64:213-221. doi: 10.1016/j.jare.2023.11.025. Epub 2023 Nov 30. J Adv Res. 2024. PMID: 38042287 Free PMC article.
-
Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes.Cardiovasc Diabetol. 2022 Jul 18;21(1):135. doi: 10.1186/s12933-022-01568-8. Cardiovasc Diabetol. 2022. PMID: 35850688 Free PMC article.
-
Impact of Extensively Hydrolyzed Infant Formula on Circulating Lipids During Early Life.Front Nutr. 2022 May 24;9:859627. doi: 10.3389/fnut.2022.859627. eCollection 2022. Front Nutr. 2022. PMID: 35685890 Free PMC article.
-
The Lipidomic Profile Is Associated with the Dietary Pattern in Subjects with and without Diabetes Mellitus from a Mediterranean Area.Nutrients. 2024 Jun 8;16(12):1805. doi: 10.3390/nu16121805. Nutrients. 2024. PMID: 38931159 Free PMC article.
-
Dietary Quality and Circulating Lipidomic Profiles in 2 Cohorts of Middle-Aged and Older Male Finnish Smokers and American Populations.J Nutr. 2023 Aug;153(8):2389-2400. doi: 10.1016/j.tjnut.2023.06.010. Epub 2023 Jun 14. J Nutr. 2023. PMID: 37328109 Free PMC article.
References
-
- Melendez‐Ramirez LY, Richards RJ, Cefalu WT. Complications of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):625‐640. - PubMed
-
- Ahola AJ, Forsblom C, Harjutsalo V, Groop P. Dietary carbohydrate intake and cardio‐metabolic risk factors in type 1 diabetes. Diabetes Res Clin Pract. 2019;155(2019):107818. - PubMed
-
- Lopes SA, Fumani C, Jornayvaz FR, Philippe J, Gastaldi G. (2018) Dyslipidemia management in patients with type 1 diabetes. Rev Med Suisse 14(609), 1118‐1122. - PubMed
-
- Vergès B. Dyslipidemia in type 1 diabetes: a masked danger. Trends Endocrinol Metab. 2020;31(6):422‐434. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous